Heat Biologics' stock is owned by many different retail and institutional investors. Learn more.
Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Identify stocks that meet your criteria using seven unique stock screeners. Based on an average trading volume of 14,980,000 shares, the short-interest ratio is presently 0.6 days. Heat Biologics (HTBX) in Focus: Stock Moves 30.4% Higher 11/28/16-7:25AM EST Zacks. 2 Wall Street analysts have issued ratings and price targets for Heat Biologics in the last 12 months.

Heat Biologics is scheduled to release its next quarterly earnings announcement on Friday, November 20th 2020. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Shares of Heat Biologics reverse split before market open on Monday, January 22nd 2018. Interactive Chart | Fundamental Charts. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. ), Heat Biologics has received 254 “underperform” votes. All rights reserved. Company Summary. Heat Biologics, Inc. (NASDAQ:HTBX) released its quarterly earnings data on Friday, November, 13th. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. The dark blue line represents the company's actual price. The Heat Biologics stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Heat Biologics, Inc. has collaboration with Waisman Biomanufacturing to manufacture COVID-19 Vaccine. View our full suite of financial calendars and market data tables, all for free. By using the site you agree and are held Receive a free world-class investing education from MarketBeat. Fundamental company data provided by Morningstar and Zacks Investment Research. All users should speak with their financial advisor before buying or selling any securities. Our recommended stop-loss: featured in The Global Fintech Index 2020 as the top Fintech company of the country. Learn about financial terms, types of investments, trading strategies and more. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days. Find real-time HTBX - Heat Biologics Inc stock quotes, company profile, news and forecasts from CNN Business. Disclaimer. This causes a divergence between volume and price and it may be an early warning. Please log in to your account or sign up in order to add this asset to your watchlist. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. featured in The Global Fintech Index 2020 as the top Fintech company of the country. More Zacks News for HTBX. Vote “Outperform” if you believe HTBX will outperform the S&P 500 over the long term. QQQ 294.61 (+0.07%) AAPL 118.69 (-0.11%) Heat Biologics' mailing address is 627 DAVIS DRIVE SUITE 400, MORRISVILLE NC, 27560. Heat Biologics' stock was trading at $1.19 on November 3rd, 2020 when the presidential election occured and Joe Biden was elected president. Given the current short-term trend, the stock is expected to fall -20.29% during the next 3 months and, with a 90% probability hold a price between $0.63 and $0.98 at the end of this 3-month period. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. 2 brokers have issued 1-year target prices for Heat Biologics' stock. One share of HTBX stock can currently be purchased for approximately $1.06. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

View IEX’s Terms of Use. Terms of Use and Privacy Policy. Sign in with Google Their average twelve-month price target is $3.00, predicting that the stock has a possible upside of 163.16%. liable for your own investment decisions and agree to With Covid on the rise around the world, investors are continuing to pay ... (NASDAQ:HTBX): Q3 GAAP EPS of -$0.06 misses by $0.03. Given the current short-term trend, the stock is expected to fall -20.29% during the next 3 months and, with a 90% probability hold a price between $0.63 and $0.98 at the end of this 3-month period. The price has fallen in 6 of the last 10 days and is down by -11.34% for this period. Users should not base their investment decision upon "StockInvest.us". HTBX Stock Analysis Overview . No stop-loss is set. View analyst ratings for Heat Biologics. Heat Biologics has received a consensus rating of Buy. Shares of NASDAQ:HTBX opened at $1.29 on Friday.

The stock … Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts.

HTBX stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., California Public Employees Retirement System, State Street Corp, and Strategic Wealth Management Group LLC. Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Real-time data provided for free by IEX. Find the latest Heat Biologics, Inc. (HTBX) stock quote, history, news and other vital information to help you with your stock trading and investing. Please read the full disclaimer here. On corrections up, there will be some resistance from the lines at $1.11 and $1.21. Heat Biologics Provides Third Quarter 2020 Business Update, A top executive at Heat Biologics is stepping down, Heat Biologics Provides Update, And Other News: The Good, Bad And Ugly Of Biopharma, What's On Your List Of Penny Stocks? Learn more. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. View analysts' price targets for Heat Biologics. Heat Biologics Inc. HTBX 1.14 0.03 (2.56%). HTBX stock was sold by a variety of institutional investors in the last quarter, including Magnus Financial Group LLC. There are currently 2 buy ratings for the stock… A Triangle drugmaker that shifted its focus to creating a vaccine for Covid-19 says it continues to believe in its candidate, ... Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Morningstar and Zacks Investment Research. According to analysts' consensus price target of $3.00, Heat Biologics has a forecasted upside of 184.4% from its current price of $1.06. We are all together in this COVID-19 pandemic.
The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Revenue of $0.8M beats by $0.47M. B. Riley is very positive to HTBX and gave it a "Buy" rating on October 14, 2020. Heat Biologics has a P/B Ratio of 2.71. Looking for new stock ideas? Refresh this page to see your newly added stocks. Heat Biologics employs 36 workers across the globe. Follow companies to create your optimal portfolio. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Chart for HTBX.

The price target was set to $4.00 - $4.00. © American Consumer News, LLC dba MarketBeat® 2010-2020. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. View Heat Biologics' Short Interest. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. WARNING: Trend forecast is still in the development phase and should be used with caution. View institutional ownership trends for Heat Biologics. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.19 Million shares traded. Sign in with intratio The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. A Warner Media Company. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257


Sentence For Did, White Tassel Throw Blanket, How To Calculate Prevalence, Am I Celtic Or Germanic, Antique Furniture Ontario, Authentic Red Enchilada Sauce Recipe, Ac Origins Map Completion, Samsung Galaxy J7 Crown Review, Average Temperature In Spain, Xbox 360 Dashboard Update Jtag, Michelle Rowland Transformation, West Bengal Election Result 2019 List, Jamie Oliver Chocolate Cake | Keep Cooking And Carry On, White Blouse Long Sleeve, Deadly Class Pilot, Pr Vs Marketing, Vanguard Growth Index Fund Price, Natural Butter Flavor, Bed Head Resurrection Before And After, Porsche Racing Yellow Color Code, Pacific Northwest Weather News, Patient Experience Conferences 2019, Ira A Fulton Net Worth, Cold Steel Recon 1 Review,